-
Zhao Zean，Jiang Yu，Chen Yanyu，Wu Ting，Lan Qunsheng，Li Yongmei，Li Lu，Yang Yang，Lin Cuiting，Cao Ying，Zhou Pingzheng，Guo Jiayin，Tian Yuanxin，Pang Jianxin.CDER167,a dual inhibitor of URATl and GLUT9,is a novel and potent uricosuric candidate for the treatment of hyperuricemia[J].中国药理学报,2022,第1期
-
Xuan Ni，Zhuang-zhuang Yang，Ling-qun Ye，Xing-long Han，Dan-dan Zhao，Feng-yue Ding，Nan Ding，Hong-chun Wu，Miao Yu，Guang-yin Xu，Zhen-ao Zhao，Wei Lei，Shi-jun Hu（Department of Cardiovascular Surgery of the First Affiliated Hospital&Institute for Cardiovascular Science；Institute of Neuroscience；Institute of Microcirculation）.Establishment of an in vitro safety assessment model for lipid-lowering drugs using same-origin human pluripotent stem cell-derived cardiomyocytes and endothelial cells[J].中国药理学报(英文版),2022,第1期
-
Jie Huang，Yang Liu，Jia-xin Chen，Xin-ya Lu，Wen-jia Zhu，Le Qin，Zi-xuan Xun，Qiu-yi Zheng，Er-min Li，Ning Sun，Chen Xu，Hai-yan Chen（Department of Physiology and Pathophysiology；Department of Echocardiography；Shanghai Key Lab of Birth Defect；Research Center on Aging and Medicine）.Harmine is an effective therapeutic small molecule for the treatment of cardiac hypertrophy[J].中国药理学报(英文版),2022,第1期
-
Jin-ping Pang，Chao Shen，Wen-fang Zhou，Yun-xia Wang，Lu-hu Shan，Xin Chai，Ying Shao，Xue-ping Hu，Feng Zhu，Dan-yan Zhu，Li Xiao，Lei Xu，Xiao-hong Xu，Dan Li，Ting-jun Hou（Hangzhou Institute of Innovative Medicine；Institute of Cancer Research and Basic Medical Sciences of Chinese Academy of Sciences；School of Life Science；Institute of Bioinformatics and Medical Engineering；State Key Lab of CAD&CG）.Discovery of novel antagonists targeting the DNA binding domain of androgen receptor by integrated docking-based virtual screening and bioassays[J].中国药理学报(英文版),2022,第1期
-
Wei Nie，Min-juan Hu，Qin Zhang，Jun Lu，Fang-fei Qian，Le-le Zhang，Fang Hu，Chang-hui Li，Shu-hui Cao，Jing-wen Li，Yue Wang，Xue-yan Zhang，Mi-die Xu，Bao-hui Han（Department of Pulmonary Medicine；Department of Radiation Oncology；Department of Pathology；Department of Oncology；Institute of Pathology）.DUBR suppresses migration and invasion of human lung adenocarcinoma cells via ZBTB11-mediated inhibition of oxidative phosphorylation[J].中国药理学报(英文版),2022,第1期
-
Xue-qing Liu，Shan Xue，Jia-bo Xu，Heng Ge，Qing Mao，Xin-hui Xu，Han-dong Jiang（Department of Respiratory and Critical Care Medicine；Department of Intensive Infection；Department of Cardiology；Department of Neurosurgery；Department of Emergency）.Clinical characteristics and related risk factors of disease severity in 101 COVID-19 patients hospitalized in Wuhan,China[J].中国药理学报(英文版),2022,第1期
-
Xi Zhang，Yu-ting Duan，Yi Wang，Xing-dong Zhao，Yi-ming Sun，Dong-ze Lin，Yi Chen，Yu-xiang Wang，Zu-wen Zhou，Yan-xin Liu，Li-hua Jiang，Mei-yu Geng，Jian Ding，Ling-hua Meng（Division of Anti-tumor Pharmacology；University of Chinese Academy of Sciences；Fochon Pharmaceuticals；Division of Anti-Tumor Pharmacology）.SAF-248,a novel PI3Kδ-selective inhibitor,potently suppresses the growth of diffuse large B-cell lymphoma[J].中国药理学报(英文版),2022,第1期
-
Zhang Xi，Duan Yuting，Wang Yi，Zhao Xingdong，Sun Yiming，Lin Dongze，Chen Yi，Wang Yuxiang，Zhou Zuwen，Liu Yanxin，Jiang Lihua，Geng Meiyu，Ding Jian，Meng Linghua.SAF-248,a novel PI3Kdelta-selective inhibitor,potently suppresses the growth of diffuse large B-cell lymphoma[J].中国药理学报,2022,第1期
-
Stefan Wörner，Bernhard N.Bohnert，Matthias Wörn，Mengyun Xiao，Andrea Janessa，Andreas L.Birkenfeld，Kerstin Amann，Christoph Daniel，Ferruh Artunc（Division of Endocrinology；Institute of Diabetes Research and Metabolic Diseases（IDM）of the Helmholtz Center Munich at the University Tübingen；German Center for Diabetes Research（DZD）at the University Tübingen；Department of Nephropathology）.Renal effects of the serine protease inhibitor aprotinin in healthy conscious mice[J].中国药理学报(英文版),2022,第1期
-
Wang Meisa，Han Qiushuang，Jia Zhirong，Chen Chuansheng，Qiao Chen，Liu Qianqian，Zhang Yameng，Wang Kaiwei，Wang Jie，Xiao Kang，Ding Xuansheng.PPARalpha agonist fenofibrate relieves acquired resistance to gefitinib in non-small cell lung cancer by promoting apoptosis via PPARalpha/AMPK/AKT/FoxO1 pathway[J].中国药理学报,2022,第1期
|